Current Issue

Issue: 53
Volume: 18 - No: 2
2022 - May-August

10th Year Message from our Founder (April, 2015)

Distinguished Members of the Medical Society,

Exactly ten years ago this time, I announced good news to you about the commencement of the publication life of our journal and shared our expectations about the future. The greatest happiness to us is, that with our fruitful cooperation we have greatly achieved beyond our target set on those days. Now, we have a journal that has been spotted in the British Library shelves and additionally, accepted by a number of national and international indexes and libraries.  We are proud of reaching the point where we are receiving international article submissions, besides being a valuable platform for scientific studies carried out in our country. The multidisciplinary nature and peculiar number of scientists that our journal reaches, give us further happiness. I would like to thank our Editorial Board firstly, and then everyone who contributed to this success.

Parallel to the success of Nobel Medicus, we as a company, also have made significant progress in our science-based and global projects. Nowadays, we are in the effort of preparation of molecules which will be the first to be entirely developed by Turkey’s own resources. Last year, when we celebrated our 50th anniversary, we experienced the honor of being the only company selected for the program of “Production and Development of Indigenous Biosimilar Drugs” that is led by TUBITAK. I am looking forward to share with you more success stories in the near future.

I hope the forthcoming decade leads our journal to novel developments and that it reaches a level where studies, not only in Turkish but also in different languages, are  published and followed in a wider geography.

I believe that your interest and support to date will continue increasingly and I hereby wish healthy days to our medical society.


Founder's Message (April, 2005)

Dear Members of the Health Sector,

Research & Development are the two complementary musts for a pharmaceutical company throughout the world. Actually, these are the musts for all the sectors and even the first condition for becoming and maintaining the status of a developed country. Despite the awareness of this necessity and the presence of estimable and talented scientists in our country, the funds and the importance allocated to R&D by the state and the private sector is unfortunately insufficient. R&D can not be carried out with only individual initiatives. In the name of our nation, it is the duty of all of us; the state, the private sector and the individuals, to jointly act and to undertake this responsibility together. For the future of our country, of our people and of our children, we need to invest more in R&D and to create new opportunities. We have to be aware of our experiences’ value, to grow-up, educate and train the scientists of tomorrow and to grant development opportunities for the talented persons. With this target, as Ulkar Holding, we enhance our activities and fulfill a part of our duties within our R&D center, FARGEM.

The idea of Nobel Medicus appeared many years ago as a hope; to bring to light the scope of the accumulated knowledge. Since then, the idea has matured, and with your most valuable participation, Nobel Medicus is now published. At the same time, we wish to contribute to the growth of knowledge and to settle an effective collaboration network among our esteemed scientists. With the enthusiasm of this first edition, we are encouraged to share our belief with you.

At this occasion, I would like to express my thanks to the edition team and to each person who contributed to give life to Nobel Medicus. With the hope to form Turkey into a centre of knowledge, science and culture, my wishes are for a healthy life.